92 related articles for article (PubMed ID: 3703891)
1. Lack of evidence for the involvement of catecholaminergic mechanisms in the behavioral anti-methamphetamine effect of L-histidine in the mouse.
Itoh Y; Oishi R; Nishibori M; Saeki K; Furuno K; Fukuda T; Araki Y
Pharmacol Biochem Behav; 1986 Mar; 24(3):571-4. PubMed ID: 3703891
[TBL] [Abstract][Full Text] [Related]
2. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice.
Kubota Y; Ito C; Sakurai E; Sakurai E; Watanabe T; Ohtsu H
J Neurochem; 2002 Nov; 83(4):837-45. PubMed ID: 12421355
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by antimanic drugs of hyperactivity induced by methamphetamine-chlordiazepoxide mixture in mice.
Okada K; Oishi R; Saeki K
Pharmacol Biochem Behav; 1990 Apr; 35(4):897-901. PubMed ID: 2345763
[TBL] [Abstract][Full Text] [Related]
4. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
Knoll J; Miklya I
Arch Int Pharmacodyn Ther; 1994; 328(1):1-15. PubMed ID: 7893186
[TBL] [Abstract][Full Text] [Related]
5. The role of the catecholaminergic system in footshock-induced fighting in mice.
Roliński Z; Kozak W
Psychopharmacology (Berl); 1979 Nov; 65(3):285-90. PubMed ID: 117501
[No Abstract] [Full Text] [Related]
6. Rimcazole (BW 234 U) and regional monoamine concentrations in mouse brain.
Hadfield MG; Milio C
Life Sci; 1987 May; 40(21):2087-90. PubMed ID: 2884541
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the in vivo action of (R)-salsolinol, an endogenous metabolite of alcohol, on serotonin and dopamine metabolism: a microdialysis study.
Nakahara D; Maruyama W; Hashiguti H; Naoi M
Brain Res; 1994 May; 644(2):226-32. PubMed ID: 8050034
[TBL] [Abstract][Full Text] [Related]
8. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
Messiha FS
Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
[TBL] [Abstract][Full Text] [Related]
9. Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice.
Itoh Y; Nishibori M; Oishi R; Saeki K
Neurosci Lett; 1984 Aug; 48(3):305-9. PubMed ID: 6541326
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice.
Yamanaka Y; Yamamoto T; Egashira T
Jpn J Pharmacol; 1983 Feb; 33(1):33-40. PubMed ID: 6683768
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of S-adenosyl-L-methionine on catecholaminergic central function.
Losada ME; Rubio MC
Eur J Pharmacol; 1989 Apr; 163(2-3):353-6. PubMed ID: 2566505
[TBL] [Abstract][Full Text] [Related]
12. Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Battaglia G; Gesi M; Lenzi P; Busceti CL; Soldani P; Orzi F; Rampello L; Nicoletti F; Ruggieri S; Fornai F
Ann N Y Acad Sci; 2002 Jun; 965():254-66. PubMed ID: 12105101
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.
Morisset S; Pilon C; Tardivel-Lacombe J; Weinstein D; Rostene W; Betancur C; Sokoloff P; Schwartz JC; Arrang JM
J Pharmacol Exp Ther; 2002 Feb; 300(2):621-8. PubMed ID: 11805225
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-hydroxytryptophan on brain levels of dopamine, norepinephrine, and serotonin in mice.
Everett GM
Adv Biochem Psychopharmacol; 1974; 10():261-2. PubMed ID: 4546516
[No Abstract] [Full Text] [Related]
15. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
Guldberg HC; Yates CM
Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
[TBL] [Abstract][Full Text] [Related]
16. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.
Seiden LS; Fischman MW; Schuster CR
Drug Alcohol Depend; 1976 Feb; 1(3):215-9. PubMed ID: 828106
[No Abstract] [Full Text] [Related]
17. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
Dunn AJ; Berridge CW
Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934
[TBL] [Abstract][Full Text] [Related]
18. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
Rastoge RB; Singhal RL
J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
[TBL] [Abstract][Full Text] [Related]
19. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
[TBL] [Abstract][Full Text] [Related]
20. Lithium suppresses elevated behavioural activity and brain catecholamines in developing hyperthyroid rats.
Rastogi RB; Singhal RL
Can J Physiol Pharmacol; 1977 Jun; 55(3):490-5. PubMed ID: 18270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
